The impact of informing psychiatric patients about their medication: a systematic review

Desplenter, Franciska; Simoens, Steven; Laekeman, Gert

doi:10.1007/s11096-006-9054-2

Cited by 48 publications

(32 citation statements)

References 43 publications

(124 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is particularly important with psychiatric medications, as nonadherence can produce withdrawal symptoms or rebound of psychiatric symptoms that could undermine substance use and/or psychiatric treatment attempts (see Blaschke et al, 2012 for review). Regular feedback on adherence could itself also function as an intervention by making the participant more aware of his/her adherence levels (Desplenter et al, 2006; Reich, 2013), and this general approach has been recommended for use in clinical practice (Julius et al, 2009). The low overall rate (55%) of MEMS cap based adherence in this study indicate that electronic monitoring by itself may not have been sufficient to promote high levels of adherence, and that patients may have benefited from feedback or other interventions targeting low adherence.…”

Section: Discussionmentioning

confidence: 99%

Comparison of methods to assess psychiatric medication adherence in methadone-maintained patients with co-occurring psychiatric disorder

Dunn

King

Brooner

2016

Drug and Alcohol Dependence

View full text Add to dashboard Cite

Background Adherence with psychiatric medication is a critical issue that has serious individual and public health implications. This is a secondary analysis of a large-scale clinical treatment trial of co-occurring substance use and psychiatric disorder. Method Participants (n=153) who received a clinically-indicated psychiatric medication >30 days during the 12-month study and provided corresponding data from Medication Event Monitoring System (MEMS) and Morisky Medication Taking Adherence Scale (MMAS) self-report adherence ratings were included in the analyses. Accuracy in MEMS caps openings was customized to each participant’s unique required dosing schedule. Results Consistent with expectations, MEMS-based adherence declined slowly over time, though MMAS scores of forgetting medication remained high and did not change over the 12-month study. MEMS caps openings were not significantly impacted by any baseline or treatment level variables, whereas MMAS scores were significantly associated with younger age and presence of an Axis I disorder and antisocial personality disorder, or any cluster B diagnoses. Conclusions Results suggest that MEMS caps may be a more objective method for monitoring adherence in patients with co-occurring substance use and psychiatric disorder relative to the MMAS self-report. Participants in this study were able to successfully use the MEMS caps for a 12-month period with <1% lost or broken caps, suggesting this comorbid population is able to use the MEMS successfully. Ultimately, these data suggest that an objective method for monitoring adherence in this treatment population yield more accurate outcomes relative to self-report.

show abstract

Section: Discussionmentioning

confidence: 99%

Comparison of methods to assess psychiatric medication adherence in methadone-maintained patients with co-occurring psychiatric disorder

Dunn

King

Brooner

2016

Drug and Alcohol Dependence

View full text Add to dashboard Cite

show abstract

“…The format and content of such interventions should be designed according to the patients' needs. A combination of oral and written information as well as easy understandable information has shown to be more effective [32]. We recommend hospitals to communicate to their staff members that pharmacists can be involved in medication counseling and that patients might be referred to them whenever needed.…”

Section: Discussionmentioning

confidence: 99%

Constraints and perspectives of pharmacists counseling patients with depression at hospital discharge

2011

View full text Add to dashboard Cite

show abstract

“…In particular, those who are young and employed want more involvement in decision making. Moreover, giving patients information about their medication seems, on the whole, to slightly improve rather than reduce adherence (Desplenter et al, 2006). Although this effect may be attenuated by more severe illness (Tilley & Chambers, 2000), it does not seem to tip over into the negative.…”

Section: What Do Patients Themselves Want?mentioning

confidence: 99%

Using written information in clinical work with patients and carers

Timms¹,

Ramsay²,

Byfield³

2008

Adv. psychiatr. treat

View full text Add to dashboard Cite

There are pitifully few examples of good com munication of information to patients in psychiatry. Pollock et al (2004) used focus groups to look at the situation on an inpatient ward. Patients and carers felt that information about their medication was helpful, reassuring -and generally absent. Written information was particularly valued because it could be read and absorbed over a period of time. However, this information was not there -not even the manufacturers' leaflets that would usually be included with medication dispensed from a chemist in the community. Staff were often busy and patients tended to feel that their concerns and questions were not important enough for staff to spend time on them. So, even in a restricted and highly controlled environment, information is lack ing, jeopardising an opportunity for patients to be constructively involved in their care and recovery. These findings would be recognisable in most mental health wards in the UK. We suspect that the same is true of most community services, but are not aware of similar studies in such settings. One, carried out among mental health workers in primary care, found that although staff were aware of goodquality information for patients, it was not readily available to them (Blackburn, 2001).Some psychiatrists might feel that their skills in communication render leaflets redundant. There is surprisingly little published evidence on psychiatrists' communication skills, but one Using written information in clinical work with patients and carers Philip Timms, Rosalind Ramsay & Roslyn ByfieldAbstract In all areas of medicine there is increasing awareness that patients need information that is clear, relevant and appropriately timed. This is obviously connected with ethical concerns of patient dignity and autonomy, but it also underpins the principle of informed choice. It is not possible to make an informed choice about how you want a problem to be managed, if you do not have the relevant information. Doctors have, historically, been poor communicators of such information. Although, on the face of it, this seems a straightforward issue to rectify, there are a surprising number of practical problems to be addressed before such communication can become a reality in daily practice.

show abstract

The impact of informing psychiatric patients about their medication: a systematic review

Cited by 48 publications

References 43 publications

Comparison of methods to assess psychiatric medication adherence in methadone-maintained patients with co-occurring psychiatric disorder

Comparison of methods to assess psychiatric medication adherence in methadone-maintained patients with co-occurring psychiatric disorder

Constraints and perspectives of pharmacists counseling patients with depression at hospital discharge

Using written information in clinical work with patients and carers

Contact Info

Product

Resources

About